ClinicalTrials.gg
RecruitingNCT07375667Updated Jan 29, 2026

Dynamic Airway Resistance & ML: Guide Sputum Suction in Ventilated Patients

An interventional study of The dynamics of airway resistance and conventional suctioning in Mechanical Ventilation Pressure High, Ventilator-Associated Pneumonia (VAP) and Respiratory Depression Neonatal, sponsored by Affiliated Hospital of Nantong University. Recruiting at 3 sites in China. Open to participants aged 18 Years to 90 Years. Per ClinicalTrials.gov, last updated 2026-01-29.

Sponsored by Affiliated Hospital of Nantong University · Not applicable, Interventional, and Supportive care

How we know

From the registry’s dates

  • Started Oct 2025; still recruiting 1 year later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
258
Allocation
Randomized
Ages
18 Years to 90 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 26 studies in Pneumonia, Ventilator-Associated with a site in China — 10 open to participants now, 11 under way, none of them phase 3. Pneumonia, Ventilator-Associated · China.

Planned enrollment
6th of 17
258 · median 174
Started
2025
with 4 others
No phase
6 of 26
4 open now
Primary completion
2028-12
later than 10 of 10 live
Registered
23rd of 26
by date
Lead sponsor
1 of 26
Affiliated Hospital of Nantong University

Among the 26 studies in Pneumonia, Ventilator-Associated with a site in China, this one is the 6th largest by planned enrollment of the 17 interventional ones that give a count, is one of 5 that started in 2025, is one of 6 with no phase, reaches primary completion later than 10 of the 10 other live ones, and was the 23rd registered.

Pneumonia, Ventilator-Associated

420 studies on the registry are indexed under Pneumonia, Ventilator-Associated; 83 are open to participants now.

Browse Pneumonia, Ventilator-Associated studies →

Open to participants now

10 of the 26 studies in Pneumonia, Ventilator-Associated with a site in China are open now. Recruiting first, the newest first:

4 more — sign in →

All 10 open studies →

A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →

Who these studies take

Of the 47 Pneumonia, Ventilator-Associated studies recruiting now, 36 (77%) set no upper age limit and 6 (13%) stop at 75 or younger; 6 take children under 18; 4 take healthy volunteers.

This study: 18 Years to 90 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 26 studies in Pneumonia, Ventilator-Associated with a site in China, or all of them as a file.
02

Study summary

Research has shown that timely suctioning not only improves survival rates but also enhances the quality of life in ventilator-dependent patients. However, clinical judgment on the optimal timing for suctioning currently relies primarily on physician experience, lacking scientific evidence [10]. Airway viscous resistance reflects the frictional resistance encountered by gas flow within the airways and is closely associated with airway patency. When airway secretions increase, viscous resistance undergoes dynamic changes. Therefore, analyzing these dynamic variations in viscous resistance derived from ventilator waveforms to determine the optimal suctioning timing and assess its clinical impact on the progression of pulmonary inflammation holds significant scientific value and offers new insights and methodologies for clinical practice.

Read the detailed description

To validate the clinical feasibility and reliability of airway viscous resistance monitoring, explore the temporal correlation between inflammatory biomarkers and changes in airway viscous resistance, establish a reference threshold system for special populations, and provide experimental evidence for determining the optimal suctioning timing.

03

Conditions studied

  • Mechanical Ventilation Pressure High
  • Ventilator-Associated Pneumonia (VAP)
  • Respiratory Depression Neonatal

Keywords

  • Airway resistance
04

Who can participate

Ages eligible
18 Years to 90 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Clinical diagnosis of Acute Respiratory Distress Syndrome (ARDS)
  • Clinical diagnosis of Acute Exacerbation of (AECOPD)
  • Clinical diagnosis of Severe pneumonia

Exclusion criteria

Exclusion Criteria:

  • Clinical diagnosis of multiple organ failure;
  • Clinical diagnosis of multiple organ bleeding;
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

COPD

Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Participant)
Enrollment
258 participants (estimated)

Study arms

  • Experimental
    Airway resistance-guided sputum suction

    Investigators will continuously monitor the airway viscous resistance of patients, and initiate suctioning when the airway viscous resistance increases by ≥6 cmH₂O.

    Procedure: The dynamics of airway resistance · Diagnostic Test: conventional suctioning

  • No intervention
    conventional suctioning

    In the control group, the decision to suction was made based on conventional clinical signs, including rhonchi and a rise in peak pressure.

Interventions

  • ProcedureThe dynamics of airway resistance

    Monitoring the dynamic changes in airway resistance in patients can be used to reflect the progression of pulmonary inflammation and determine the optimal timing for suctioning.

  • Diagnostic testconventional suctioning

    The timing for suctioning is determined based on clinical signs such as rhonchi and an elevated peak pressure.

06

What researchers measure

Primary outcomes

  1. The drop in airway viscous resistance before and after sputum suction

    Airway viscous resistance drop (AVRD) is the primary efficacy endpoint of this study. It is defined as the difference in airway viscous resistance measured immediately before and after suctioning. Procedure: Record the ventilator-displayed viscous resistance value pre-suction; immediately after the maneuver, re-measure both viscous resistance and peak airway pressure with a high-precision pressure-time sensor. Calculation: The within-patient difference (pre minus post) is the AVRD. In a pilot study of nine patients, AVRD averaged 6.889 ± 3.551 cmH₂O, significantly larger than the concurrent peak-pressure drop (1.556 ± 1.740 cmH₂O), indicating that AVRD is more sensitive to the effect of suction on airway secretions. Clinical implication: AVRD can serve as a quantitative criterion for determining the optimal timing of endotracheal suction.

    Time frame: the process of sputum aspiration(at most 30 minutes)

Secondary outcomes

  1. The number of participants with abnormal laboratory tests

    Venous blood testing was performed, including a complete blood count (white blood cell count \[WBC\], neutrophil percentage \[NEUT%\]), C-reactive protein (CRP), and procalcitonin (PCT) to assess the systemic inflammatory status.

    Time frame: Laboratory testing time ( at least 30 minutes)

  2. Sputum bacterial culture

    Sputum culture is performed to identify the source of infection and to diagnose VAP.

    Time frame: 3 days

07

Study locations

3 of 3 sites recruiting
08

References and documents

Individual participant data

Plan to share: Yes — All data

Supporting information: Clinical study report

Time frame: From October 2025 until the end of the trial

Access criteria: Critical care researchers; all materials will be made available. Contact: Honglei Wu, e-mail: wu_honglei@163.com

Data sharing details ↗ · www.ahnmc.com

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Oct 2025 (actual). Primary completion is estimated for Dec 2028, 38 months after the start.

Of 82 non-industry interventional studies with no phase under Pneumonia, Ventilator-Associated, half reached primary completion within 20 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 36. This study's planned 38 months is above that.

Counting every sponsor, half of 83 studies reached it within 20 months; a quarter within 10 and three quarters within 36.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 10, 2025
First posted
Jan 29, 2026
StartActual
Oct 30, 2025
Primary completionEst.
Dec 30, 2028
CompletionEst.
Dec 30, 2029
Last update
Jan 29, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 29, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07375667
Lead sponsor
Affiliated Hospital of Nantong University
Responsible party
Sponsor
First posted
Jan 29, 2026
Start date
Oct 30, 2025
Primary completion
Dec 30, 2028 (estimated)
Completion
Dec 30, 2029 (estimated)
Last update
Jan 29, 2026

Study contacts

Hong-lei Wu Nursing Department, MS
Contact
wu_honglei@163.com
+8613862749927
xuan Qian Nursing Department, MS
Contact
1660694568@qq.com
+8615162763676

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion